对化疗毒性及其预防的新认识
Ronit Juthani1,2, Sachin Punatar2,3, Indraneel Mittra4,5
1Translational Research Laboratory, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Kharghar, Navi Mumbai, 410210, India.
BJC reports
|November 8, 2024
概括
化疗的副作用或化学毒性可能是由死亡细胞释放的无细胞染色素颗粒 (cfChPs) 引起的. 关闭cfChPs,可能与白醇和铜 (R-Cu) 关闭,可以减少这些毒性作用.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 化疗是癌症治疗的基石,但会导致严重的副作用 (化学毒性).
- 化学毒性传统上归因于化学疗法药物对健康细胞的直接损伤.
- 新出现的证据表明,化学毒性是死细胞释放的无细胞染色素颗粒 (cfChPs) 的次要效应.
研究的目的:
- 审查有关化学毒性机制和预防策略的新兴研究.
- 突出cfChPs在调解化疗诱导的副作用中的作用.
- 讨论cfChPs失活剂的潜力,特别是白醇和铜 (R-Cu),用于临床使用.
主要方法:
- 审查实验室,临床前和早期临床试验数据.
- 对cfChPs诱导旁观细胞中DNA损伤和炎症的机制的分析.
- 识别和评估潜在的cfChPs-失效剂.
主要成果:
- 化疗诱导的细胞死亡释放cfChP,破坏健康细胞,导致DNA断裂和炎症.
- 这种cfChP释放会加剧和延长化学毒性.
- 复星和铜 (R-Cu) 组合显示,作为口服药物,它具有很低的毒性,可以使cfChPs失活.
结论:
- 化学毒性可能是cfChPs介导的次要效应,挑战了传统的理解.
- 禁用cfChP是一种新的策略,可以减轻化疗副作用.
- 在随机临床试验中,R-Cu营养药物组合值得进一步研究其在管理化学毒性的治疗潜力.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
174
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
174
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
148
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
148
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
226
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
226
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Toxic Reactions: Overview
948
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
948


